BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 10798217)

  • 1. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo.
    Chew BP; Park JS; Wong MW; Wong TS
    Anticancer Res; 1999; 19(3A):1849-53. PubMed ID: 10470126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary beta-carotene and astaxanthin but not canthaxanthin stimulate splenocyte function in mice.
    Chew BP; Wong MW; Park JS; Wong TS
    Anticancer Res; 1999; 19(6B):5223-7. PubMed ID: 10697539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice.
    Nakao R; Nelson OL; Park JS; Mathison BD; Thompson PA; Chew BP
    Anticancer Res; 2010 Jun; 30(6):2171-5. PubMed ID: 20651366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens.
    Jyonouchi H; Zhang L; Gross M; Tomita Y
    Nutr Cancer; 1994; 21(1):47-58. PubMed ID: 8183722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary lutein but not astaxanthin or beta-carotene increases pim-1 gene expression in murine lymphocytes.
    Park JS; Chew BP; Wong TS; Zhang JX; Magnuson NS
    Nutr Cancer; 1999; 33(2):206-12. PubMed ID: 10368818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological role of vitamin A and its related substances in prevention of cancer.
    Tomita Y
    Nutr Cancer; 1983; 5(3-4):187-94. PubMed ID: 6669479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of Chlorella vulgaris augments concomitant antitumor immunity.
    Tanaka K; Tomita Y; Tsuruta M; Konishi F; Okuda M; Himeno K; Nomoto K
    Immunopharmacol Immunotoxicol; 1990; 12(2):277-91. PubMed ID: 2229925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E; Maeda H
    Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone can improve the anti-tumor immunity by reducing the CD4+CD25+Foxp3+ regulatory T cells in BALB/c mice.
    Molla Hassan AT; Hassan ZM; Moazzeni SM; Mostafaie A; Shahabi S; Ebtekar M; Hashemi SM
    Int Immunopharmacol; 2009 Nov; 9(12):1381-6. PubMed ID: 19706340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor growth and enhancement of immune status with high levels of dietary vitamin B6 in BALB/c mice.
    Gridley DS; Stickney DR; Nutter RL; Slater JM; Shultz TD
    J Natl Cancer Inst; 1987 May; 78(5):951-9. PubMed ID: 3472003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang).
    Harada M; Seta K; Ito O; Tamada K; Li T; Terao H; Takenoyama M; Kimura G; Nomoto K
    Immunopharmacol Immunotoxicol; 1995 Nov; 17(4):687-703. PubMed ID: 8537606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prolonged administration of low doses of dietary retinoids on cell-mediated immunity and the growth of transplantable tumors in mice.
    Forni G; Cerruti Sola S; Giovarelli M; Santoni A; Martinetto P; Vietti D
    J Natl Cancer Inst; 1986 Mar; 76(3):527-33. PubMed ID: 3081748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.